Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Wegovy is licensed in the UK in doses up to 2.4mg for weight loss and, on 14 September 2025, Novo Nordisk published results of a phase IIIb clinical trial (STEP UP, NCT05646706) of a 7.2mg dose of semaglutide for subcutaneous injection 1
With the right care, tirzepatide continues to be a helpful tool for improving health without serious heart concerns for most users
Co-immunoprecipitation data was analyzed by t-test, or one-way ANOVA followed by Bonferroni post-hoc test
Indeed, Ghashghaeinia et al
This places pressure on your kidneys to filter out extra water, which can worsen kidney disease
Seek urgent care for severe or persistent abdominal pain (which may indicate pancreatitis), right upper quadrant pain with fever or jaundice (possible gallbladder disease), or syncope
